| Literature DB >> 10385366 |
T Shishido1, T Yasoshima, K Hirata, R Denno, M Mukaiya, H Ura, K Yamaguchi, S Kawaguchi, N Sato.
Abstract
To investigate of human pancreatic cancer metastasis to the liver, a pancreatic carcinoma line, HPC-3, was injected into the spleens of nude mice. The cells from a few liver metastatic foci of the mice injected with HPC-3 were expanded in vitro and subsequently injected into the spleens of nude mice. By repeating these procedures, we were able to obtain a cell line, designated HPC-3H4. The mice were observed to have liver metastasis in 6 of 6 (100%) cases injected with HPC-3H4, whereas the rate was 0% at 3 weeks after the intrasplenic injection of HPC-3. The tumorigenicity of HPC-3H4 was more rapid than that of HPC-3. The motile activity of HPC-3H4 was also stronger than that of HPC-3, and the adhesion to the extracellular matrix of HPC-3H4 was stronger than that of HPC-3. We also analyzed the cell surface expression of the metastasis-related adhesion molecules. As a result, no substantial changes were observed in the expression level of adhesion molecules. These results suggest that HPC-3H4 is useful for studies aimed at the prevention of liver metastasis.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10385366 DOI: 10.1007/BF02482346
Source DB: PubMed Journal: Surg Today ISSN: 0941-1291 Impact factor: 2.549